8-K//Current report
Eloxx Pharmaceuticals, Inc. 8-K
Accession 0001104659-24-002631
CIK 0001035354operating
Filed
Jan 8, 7:00 PM ET
Accepted
Jan 9, 5:10 PM ET
Size
218.1 KB
Accession
0001104659-24-002631
Documents
- 8-Ktm242562d1_8k.htmPrimary
FORM 8-K
- EX-101.SCHelox-20240109.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABelox-20240109_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREelox-20240109_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- XMLtm242562d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-24-002631-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001035354
Filing Metadata
- Form type
- 8-K
- Filed
- Jan 8, 7:00 PM ET
- Accepted
- Jan 9, 5:10 PM ET
- Size
- 218.1 KB